Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 204.64 billion. The enterprise value is 191.25 billion.
| Market Cap | 204.64B |
| Enterprise Value | 191.25B |
Important Dates
The next estimated earnings date is Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Englewood Lab has 19.87 million shares outstanding.
| Current Share Class | 19.87M |
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 0.21% |
| Float | 6.92M |
Valuation Ratios
The trailing PE ratio is 8.15 and the forward PE ratio is 10.06.
| PE Ratio | 8.15 |
| Forward PE | 10.06 |
| PS Ratio | 1.00 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | 12.96 |
| P/OCF Ratio | 9.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.12, with an EV/FCF ratio of 12.11.
| EV / Earnings | 7.61 |
| EV / Sales | 0.93 |
| EV / EBITDA | 5.12 |
| EV / EBIT | 6.01 |
| EV / FCF | 12.11 |
Financial Position
The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.84 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.70 |
| Debt / FCF | 1.66 |
| Interest Coverage | 27.44 |
Financial Efficiency
Return on equity (ROE) is 17.85% and return on invested capital (ROIC) is 11.76%.
| Return on Equity (ROE) | 17.85% |
| Return on Assets (ROA) | 9.67% |
| Return on Invested Capital (ROIC) | 11.76% |
| Return on Capital Employed (ROCE) | 19.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.67 |
Taxes
In the past 12 months, Englewood Lab has paid 9.38 billion in taxes.
| Income Tax | 9.38B |
| Effective Tax Rate | 27.19% |
Stock Price Statistics
The stock price has increased by +52.95% in the last 52 weeks. The beta is 0.47, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +52.95% |
| 50-Day Moving Average | 12,249.00 |
| 200-Day Moving Average | 12,103.75 |
| Relative Strength Index (RSI) | 28.52 |
| Average Volume (20 Days) | 84,225 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 204.62 billion and earned 25.12 billion in profits. Earnings per share was 1,263.90.
| Revenue | 204.62B |
| Gross Profit | 53.40B |
| Operating Income | 31.81B |
| Pretax Income | 34.50B |
| Net Income | 25.12B |
| EBITDA | 37.37B |
| EBIT | 31.81B |
| Earnings Per Share (EPS) | 1,263.90 |
Balance Sheet
The company has 39.69 billion in cash and 26.30 billion in debt, with a net cash position of 13.39 billion or 674.08 per share.
| Cash & Cash Equivalents | 39.69B |
| Total Debt | 26.30B |
| Net Cash | 13.39B |
| Net Cash Per Share | 674.08 |
| Equity (Book Value) | 154.89B |
| Book Value Per Share | 7,796.15 |
| Working Capital | 115.83B |
Cash Flow
In the last 12 months, operating cash flow was 21.92 billion and capital expenditures -6.12 billion, giving a free cash flow of 15.79 billion.
| Operating Cash Flow | 21.92B |
| Capital Expenditures | -6.12B |
| Free Cash Flow | 15.79B |
| FCF Per Share | 794.99 |
Margins
Gross margin is 26.10%, with operating and profit margins of 15.55% and 12.28%.
| Gross Margin | 26.10% |
| Operating Margin | 15.55% |
| Pretax Margin | 16.86% |
| Profit Margin | 12.28% |
| EBITDA Margin | 18.26% |
| EBIT Margin | 15.55% |
| FCF Margin | 7.72% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 8.66% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.94% |
| Earnings Yield | 12.27% |
| FCF Yield | 7.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 4.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.06 |
| Piotroski F-Score | 5 |